Patents by Inventor Dominique Delacroix

Dominique Delacroix has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080134082
    Abstract: A computer implemented method includes displaying a window with a first section characterizing a computing task and a second section with a progress bar and an interaction button. An overlay pane is displayed with a status message and an animation indicating that the computing task is active. The overlay pane covers at least a portion of the first section and is partially transparent such that a covered portion of the first section is visible through the overlay pane.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 5, 2008
    Applicant: BUSINESS OBJECTS, S.A.
    Inventors: Marc Dominique Delacroix, Camel Aissani, Ludovic Engrand, Arnaud Nouard
  • Patent number: 5609886
    Abstract: Microspheres which are a matrix of a biocompatible and biodegradable polymer which is soluble in an organic solvent which is immiscible in water, within which a water-soluble substance is uniformly distributed, and wherein the residual level of toxic solvent in the microspheres is lower than 1.5% by weight, progressively and continuously releases the substance over a period of at least 8 days when the microspheres are placed in an aqueous physiological environment, with a reduced or substantially absent first phase of accelerated release. A process for producing such microspheres is provided.
    Type: Grant
    Filed: July 26, 1995
    Date of Patent: March 11, 1997
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Henri Wantier, Fabienne Mathieu, Marc Baudrihaye, Dominique Delacroix
  • Patent number: 5478564
    Abstract: The subject of the present invention is a process for preparing microparticles of the microsphere type of a water-soluble substance and a biocompatible and biodegradable polymer controlling the kinetics of release of the said substance consisting of a matrix of the said polymer within which the said water-soluble substance is regularly dispersed, characterized in thata) the said polymer is dissolved in a first volatile organic solvent immiscible with water,b) the said water-soluble substance is dissolved in a second solvent which is miscible with the said first solvent, is a solvent for the polymer, and miscible with water,c) the solution of the said substance and the solution of the said polymer are mixed,d) an organic phase of the polymer and of the said substance is obtained which is then emulsified in an immiscible dispersant medium consisting of an aqueous phase containing an emulsifying agent,e) the two solvents are then removed from the microspheres being formed with stirring, the first solvent being r
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: December 26, 1995
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Henri Wantier, Fabienne Mathieu, Marc Baudrihaye, Dominique Delacroix
  • Patent number: 5456985
    Abstract: The present invention relates to micro-capsules constituted by a solid envelope consisting of a layer of coating materials including at least one gastro-resistant polymer, said solid envelope containing an oily liquid.
    Type: Grant
    Filed: July 14, 1993
    Date of Patent: October 10, 1995
    Inventors: Slim Zgoulli, Philippe Delfosse, Philippe Thonart, Dominique Delacroix
  • Patent number: 5128270
    Abstract: The invention relates to assays of a monokine in a biological fluid, in particular in a blood sample, in particular of TNF or of IL-1. According to the present invention, the monokine in the serum or plasma obtained from whole blood stimulated with a mitogenic agent is assayed prior to any separation between the plasma (or serum) and the blood cells. According to another subject of the invention, the monokine is assayed in the case of an immunometric assay employing an oligoclonal system, consisting of several different monoclonal antibodies adsorbed on a solid phase and a non-adsorbed labeled antibody.The invention also relates to immunoassay kits.
    Type: Grant
    Filed: January 6, 1989
    Date of Patent: July 7, 1992
    Assignee: Ire-Medgenix S.A.
    Inventors: Dominique Delacroix, Donat De Groote, Paul Franchimont, Philippe Gysen, Aimee Reuter, Isabelle Dehart